[ACRX] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
12-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -36.71%
YoY- -142.52%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 95 27,607 548 407 940 1,675 166 -31.09%
PBT -9,631 17,769 -10,986 -17,447 -12,762 -33,363 -8,582 7.99%
Tax -618 -1,742 -1,980 -9,273 -1,285 -22,841 390 -
NP -9,631 17,769 -10,986 -17,447 -12,762 -10,522 -8,582 7.99%
Tax Rate - 9.80% - - - - - -
Total Cost 9,726 9,838 11,534 17,854 13,702 12,197 8,748 7.32%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -10,137.89 64.36 -2,004.74 -4,286.73 -1,357.66 -628.18 -5,169.88 56.73%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -4.46 8.20 -5.30 -9.36 -6.87 -5.67 -7.58 -29.80%
EPS Diluted -4.46 8.20 -5.30 -9.36 -6.87 -5.67 -7.58 -29.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.